Sodium Channels: Function and Importance in the Body

Uncover the critical function of sodium channels, essential protein gates that govern electrical signals and underpin all major body systems.

Sodium channels are protein gateways embedded in cell membranes that allow sodium ions to rush into cells at precisely timed moments, powering everything from the electrical impulses in your nerves to the beating of your heart. They are among the most fundamental molecular machines in your body, and when even a single amino acid in their structure is altered, the consequences can range from chronic pain disorders to life-threatening cardiac arrhythmias. What makes these channels remarkable is how much the body depends on their split-second timing and exquisite selectivity for sodium over other ions.

What Sodium Channels Actually Do

Your cells maintain a careful imbalance of electrical charge across their membranes, with more sodium outside the cell and more potassium inside. Sodium channels are the controlled gates that, when triggered, let sodium flood inward. That inrush of positive charge is the spark behind an action potential, the brief electrical event that lets a nerve cell fire or a muscle cell contract. The whole process unfolds in under a millisecond.

There are two broad families of sodium channels in the body. Voltage-gated sodium channels respond to changes in the electrical voltage across a cell membrane. These are the ones responsible for nerve impulses, heartbeats, and muscle contractions. Epithelial sodium channels, by contrast, stay open more steadily and handle the quieter job of reabsorbing sodium from fluids in places like the kidneys and lungs, helping regulate blood pressure and fluid balance.

How They Pick Sodium Over Everything Else

Your blood and tissue fluids contain both sodium and potassium ions, which are roughly the same size and carry the same positive charge. So how does a sodium channel let sodium through while mostly blocking potassium? The answer lies in the channel’s selectivity filter, a narrow ring of amino acid residues near the top of the pore. In sodium channels, this ring uses a signature set of four residues, often called the DEKA motif, with one contributed by each of the channel’s four structural domains. Experiments on rat skeletal muscle sodium channels showed that the lysine residue in this motif is the critical piece: it blocks calcium from passing through and gives sodium the edge over potassium.

The selectivity is not purely a matter of pore size. Computational studies suggest that sodium channels prefer sodium in part because the pore provides fewer coordinating contacts than a potassium channel would, and those contacts carry a strong negative charge that favors the slightly smaller, less-hydrated sodium ion. More recent molecular dynamics work has added another layer: the presence of sodium versus potassium in the filter actually shifts the chemical properties of the filter’s amino acids, making the channel more conductive when sodium is present and less conductive when potassium is present. The channel does not just passively sieve ions by size; it actively changes its behavior depending on which ion arrives.

Nerve Signaling and the Action Potential

When a nerve cell receives enough stimulation, voltage-gated sodium channels at the start of its axon snap open. Sodium rushes in, the membrane voltage spikes, and an action potential is born. This process is sometimes described as an all-or-nothing event, and the threshold for firing depends on how many sodium channels are available and how responsive they are. Modeling work has shown that the threshold voltage scales with sodium channel density in a logarithmic way: you need a certain baseline number of channels, but doubling that number does not halve the threshold.

Once the action potential starts, it has to travel. In many nerve fibers, the axon is wrapped in an insulating sheath of myelin, and sodium channels are concentrated at the gaps between myelin segments, called nodes of Ranvier. This clustering is not random. A scaffolding protein called ankyrin-G anchors sodium channels at these nodes, and without it, the channels scatter and nerve conduction fails. Another structural protein, βIV-spectrin, binds to ankyrin-G at both nodes and the axon initial segment, where action potentials are first generated. In mice lacking βIV-spectrin, sodium channels fail to cluster properly at these sites, leading to impaired nerve conduction.

After opening, sodium channels do not just close and wait for the next signal. They enter an “inactivated” state, a temporary lockdown that prevents them from reopening immediately. This inactivation involves a short loop of the channel protein that physically swings into the pore like a hinged lid. A specific amino acid cluster in this loop, centered on a phenylalanine residue, acts as the latch. When researchers replaced that phenylalanine with a different amino acid in human heart sodium channels, inactivation broke down and the channel stayed open too long. This inactivation step is what keeps each nerve impulse crisp and brief, and as you will see later, disruptions to it underlie several serious diseases.

The Heartbeat Depends on a Single Channel Gene

Heart muscle uses its own dedicated sodium channel, called Nav1.5, encoded by the gene SCN5A. This channel drives the fast upstroke of the cardiac action potential, the sharp electrical spike that triggers each contraction of the heart muscle. Because every heartbeat relies on a coordinated wave of these action potentials sweeping through the heart, even subtle mutations in SCN5A can have outsized consequences.

Mutations in SCN5A cause several distinct heart rhythm disorders. Some mutations produce long QT syndrome type 3, where the channel stays open slightly too long and delays the heart’s electrical recovery, raising the risk of dangerous arrhythmias. One such mutation reduced peak sodium current by about 80% while also enlarging the persistent “late” current that should have been shut off by inactivation. Other SCN5A mutations cause Brugada syndrome, a condition where the channel fails to reach the cell surface properly, leaving the heart with too few functional channels and predisposing it to sudden cardiac arrest. The fact that different mutations in the same gene cause opposite electrical problems (too much current versus too little) makes cardiac sodium channelopathies tricky to treat.

Skeletal Muscle and the Channel That Moves You

Every time you lift a fork or take a step, skeletal muscle fibers fire action potentials using their own sodium channel subtype, Nav1.4. This channel translates nerve signals into the mechanical force of muscle contraction. Mutations in Nav1.4 cause a family of diseases including myotonia, where muscles contract normally but cannot relax, and periodic paralysis, where muscles temporarily lose the ability to contract at all. Both extremes stem from the same underlying problem: the channel’s opening, closing, or inactivation timing is thrown off, either leaving the muscle stuck in an excited state or rendering it electrically silent.

Pain Sensing and the Channels That Set Your Alarm

Pain-sensing nerve cells, called nociceptors, rely on several sodium channel subtypes to detect and transmit pain signals. Five subtypes are expressed in adult sensory neurons, but three of them, Nav1.7, Nav1.8, and Nav1.9, have attracted the most attention because genetic variants in these channels are directly linked to human pain disorders. In animal models of chronic inflammatory joint pain, all three of these channels show increased expression in the nerve cells serving the inflamed joint, suggesting they help maintain pain long after the initial injury.

The most dramatic evidence for these channels’ role in pain comes from rare human genetic conditions. The gene SCN9A encodes Nav1.7, and different mutations in it can produce opposite extremes. Loss-of-function mutations, where both copies of the gene are knocked out, cause congenital insensitivity to pain: affected individuals simply cannot feel pain at all. Gain-of-function mutations in the same gene cause erythromelalgia, a condition of severe burning pain in the hands and feet, or paroxysmal extreme pain disorder, with episodes of excruciating rectal, eye, or jaw pain. In one striking family report, an infant with one SCN9A mutation had congenital insensitivity to pain, while his mother, carrying a different mutation of the same gene, experienced hypersensitivity to pain. This has made Nav1.7 one of the most pursued drug targets in pain research, with the hope that blocking it selectively could produce powerful analgesia without the addiction risks of opioids. Progress has been slower than hoped, partly because the channel’s structure is similar enough to other sodium channel subtypes that achieving clean selectivity is difficult.

Epilepsy, Dravet Syndrome, and Inhibitory Neurons

Not all sodium channel disorders affect the heart or pain circuits. In the brain, Nav1.1 is particularly important for a specific class of inhibitory neurons, the fast-spiking GABAergic interneurons that act as the brain’s brakes. Loss-of-function mutations in SCN1A, the gene encoding Nav1.1, cause Dravet syndrome, a severe childhood epilepsy marked by frequent seizures, cognitive impairment, and a risk of premature death.

The mechanism is counterintuitive. You might expect that losing sodium channel function would make the brain quieter. Instead, because Nav1.1 is concentrated in inhibitory neurons, losing it cripples the cells whose job it is to suppress excessive excitation. The result is uncontrolled firing. Mouse experiments confirmed this directly: deleting Nav1.1 specifically in forebrain GABAergic neurons was enough to reproduce the full Dravet phenotype, including seizures and premature death, proving that the loss of inhibition is both necessary and sufficient for the disease. Even mutations that do not reduce the total amount of sodium current, but merely shift when and how the channel opens, can impair interneuron firing enough to produce a Dravet-like condition. This understanding has practical consequences for treatment: drugs that broadly block sodium channels, like carbamazepine, can actually worsen Dravet syndrome by further suppressing the already-struggling inhibitory neurons.

Blood Pressure and the Kidney’s Sodium Recycler

Epithelial sodium channels (ENaC) in the kidneys handle a quieter but equally vital job. As your kidneys filter blood, ENaC in the collecting ducts reclaims sodium that would otherwise be lost in urine. Because water follows sodium, this reclamation directly controls blood volume and blood pressure. ENaC activity is tightly regulated by the hormone aldosterone, but insulin also appears to boost ENaC activity. In rats receiving chronic insulin infusion, the response to an ENaC-blocking drug roughly doubled compared to controls, suggesting insulin drives more sodium reabsorption, and blood pressure rose accordingly. This connection may partly explain why conditions associated with high insulin levels, like type 2 diabetes, so often come with high blood pressure.

ENaC also shows up in the brain. Aldosterone can increase expression of one ENaC subunit in hypothalamic neurons involved in fluid balance, though interestingly, aldosterone alone was not enough to increase the channel’s actual sodium current in brain tissue slices, suggesting additional signals are needed.

Drugs and Toxins That Target Sodium Channels

Many of the most widely used drugs in medicine work by blocking sodium channels, though each exploits different channel states. Local anesthetics like lidocaine preferentially bind to sodium channels that are open or inactivated, meaning they are most effective in nerves that are actively firing. This “state-dependent” blocking is why a dentist’s injection numbs the area without shutting down your whole nervous system: the drug accumulates most in the busy pain-signaling nerves. The same principle extends to antiarrhythmic drugs and anticonvulsants. Their slower, higher-affinity binding to the inactivated state helps explain both their therapeutic effects and their toxicity at high doses.

Nature invented sodium channel blockers long before pharmacologists did. Tetrodotoxin, the poison found in pufferfish, plugs the outer vestibule of voltage-gated sodium channels with extraordinary potency. Researchers studying how the toxin binds found that a single glutamate residue near the outer mouth of the pore is a key contact point; mutating it dramatically reduced the toxin’s ability to latch on. This toxin has become one of the most important tools in sodium channel research, used to distinguish between channel subtypes that are sensitive to it and those that are resistant.

The Arms Race Between Snakes and Newts

One of the more fascinating chapters in sodium channel biology comes from evolutionary ecology. Certain Pacific newts produce tetrodotoxin as a defense. Garter snakes that prey on these newts have, over evolutionary time, developed mutations in their own Nav1.4 skeletal muscle sodium channels that make the channels resistant to the toxin. This is a classic coevolutionary arms race: as newts evolved more potent toxin, snakes evolved greater resistance.

What makes this story scientifically rich is how constrained the resistance mutations are. A study of six snake species from three separate lineages around the world found that resistance-conferring mutations cluster in just two regions of the channel, and most occur at only three amino acid positions, despite many other mutations being theoretically capable of conferring resistance. The resistance is not limited to the skeletal muscle channel either. In garter snakes, parallel resistance mutations have been found in Nav1.6 and Nav1.7, the channels used in peripheral nerves, suggesting the snakes had to protect multiple tissues from the toxin simultaneously. The mutations come at a cost, though. Changes that block toxin binding can also subtly impair normal channel function, which is probably why only a handful of the possible resistance mutations ever arise in nature.

Sodium Channels Older Than Nervous Systems

If sodium channels seem like a hallmark of animals with brains, it may be surprising that they predate nervous systems entirely. Researchers found genes closely resembling animal sodium channels in choanoflagellates, single-celled organisms that are the closest living relatives of animals. These organisms do not have nerves or muscles, yet they express sodium channel genes with a selectivity filter that appears intermediate between calcium and sodium channels. Similarly, placozoans, tiny animals that lack any nervous system, also retain these channels. Phylogenetic analysis suggests that sodium channels evolved from ancestral calcium channels, and the common ancestor of choanoflagellates and animals likely had a channel permeable to both sodium and calcium. Over hundreds of millions of years, these channels were tuned toward sodium selectivity, eventually becoming the fast electrical signaling tools that made complex nervous systems possible.

Sodium Channels in Cancer

A more recently recognized role for voltage-gated sodium channels is their unexpected appearance in cancer cells. Multiple types of cancer express sodium channels that the healthy version of that tissue does not normally produce. Nav1.5 turns up in breast, ovarian, and colon cancers; Nav1.6 in cervical and prostate cancers; Nav1.7 in lung cancers. The presence of these channels correlates with increased cell motility, proliferation, and metastatic potential. In breast, prostate, and lung cancer cells, blocking sodium channels with tetrodotoxin reduced migration and invasion in laboratory experiments. The sodium current carried by the channel’s main subunit appears to directly enhance invasion and metastasis.

This does not mean sodium channels cause cancer. Rather, cancer cells seem to co-opt these channels as part of their toolkit for spreading. The research is still early-stage, and no sodium channel blocker is used as a cancer treatment today. But the consistent pattern across so many cancer types has drawn enough interest that researchers are exploring whether existing sodium channel-blocking drugs might have anti-metastatic effects as a secondary benefit.

Seeing the Channel Up Close

For decades, scientists understood sodium channel function primarily through electrical recordings and mutation experiments, inferring structure from behavior. That changed with advances in cryo-electron microscopy. In 2017, researchers captured the structure of an electric eel sodium channel (Nav1.4) bound to its β1 subunit at a resolution fine enough to see individual protein domains. The structure revealed the voltage-sensing domains in their “up” (activated) conformations and showed how the β1 subunit’s immunoglobulin-like domain docks onto the main channel through extensive polar interactions. Voltage-gated sodium channels are built from one large pore-forming α subunit and two smaller β subunits that modulate how the channel behaves, reaches the cell surface, and interacts with neighboring cells. These structural snapshots have accelerated drug design by giving researchers a three-dimensional map of exactly where drugs, toxins, and disease-causing mutations interact with the channel.